Universal (UVV) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
29 May, 2026Executive summary
Fiscal 2026 performance was resilient despite market shifts, with oversupply in tobacco and headwinds in ingredients impacting volumes and margins, but disciplined management and stable revenues mitigated some effects.
Financial results were affected by a $41.1 million non-cash goodwill impairment at Shank's and significant inventory write-downs in non-wrapper dark air-cured tobacco.
Sustainability efforts advanced, with an upgrade to an A rating in the CDP Supplier Engagement Assessment and recognition as a CDP Supplier Engagement Leader.
Leadership transition included the appointment of a new CFO, Steve Diel, effective April 1.
Fourth quarter and full-year results were impacted by non-cash charges and market headwinds, particularly in the consumer-packaged-goods sector.
Financial highlights
Fiscal year 2026 consolidated revenue was $2.92 billion, down 1% year-over-year; Q4 revenue was $715 million, up 2%.
Q4 operating loss was $15 million versus $43 million operating income last year; full-year operating income was $169 million, down $64 million from FY25.
Net income attributable to shareholders was $32.6 million, down from $95 million; diluted EPS was $1.30, down from $3.78.
Adjusted diluted EPS was $2.64, a 43% decrease year-over-year.
Gross margin declined 110 basis points to 17.5% for the year; Q4 gross margin fell 270 basis points to 16.5%.
Outlook and guidance
Confident in achieving uncommitted inventory targets (10–20%) during FY27, with early signs of normalization and management expecting improvement as market activity recovers.
Enhancements at Shank's are underway to improve efficiency and financial performance.
Expect continued market headwinds in ingredients but see opportunities for growth as inflationary and tariff pressures potentially ease.
Focus remains on maximizing tobacco business, growing ingredients, and operational efficiency.
Confidence expressed in the resilience of the tobacco business and foundational progress in the ingredients segment.
Latest events from Universal
- Revenue and profit fell, but tobacco stayed strong and liquidity improved with new credit facility.UVV
Q3 20269 Feb 2026 - Q1 FY2025 revenue up 15% and operating income up 56%, with strong demand across segments.UVV
Q1 20252 Feb 2026 - Strategy centers on tobacco leadership, scaling ingredients, and sustainable, profitable growth.UVV
28th Annual ICR Conference 202613 Jan 2026 - Shareholders will vote on directors, executive pay, and auditor ratification amid strong results and ESG progress.UVV
Proxy Filing1 Dec 2025 - Proxy covers director elections, say-on-pay, auditor ratification, and strong ESG focus.UVV
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve pay, and ratify auditor, with updated proxy card.UVV
Proxy Filing1 Dec 2025 - Revenue up 7% to $2.95B, operating income up 5%, with strong segment growth and improved liquidity.UVV
Q4 202526 Nov 2025 - Operating income nearly doubled on strong tobacco margins, despite higher costs and tariff risks.UVV
Q1 202623 Nov 2025 - Revenue and net income increased, offsetting margin pressures and supporting growth initiatives.UVV
Q2 202613 Nov 2025